These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 6481791)
1. Response of the popliteal lymph node to reinfection of the hind foot pad of the mouse with Mycobacterium marinum. Mor N; Lutsky I; Levy L J Clin Lab Immunol; 1984 Jul; 14(3):155-60. PubMed ID: 6481791 [TBL] [Abstract][Full Text] [Related]
2. Role of the popliteal lymph node in infection with Mycobacterium marinum of the hind footpad of the mouse, and source of the cells that characterize the process. Mor N; Lutsky I; Levy L Scand J Immunol; 1981 May; 15(5):429-38. PubMed ID: 7345563 [TBL] [Abstract][Full Text] [Related]
3. Response in the hindfoot pad and popliteal lymph node of C57BL mice to infection with Mycobacterium marinum. Mor N; Lutsky I; Levy L Isr J Med Sci; 1981 Apr; 17(4):236-44. PubMed ID: 7239868 [TBL] [Abstract][Full Text] [Related]
4. Protection of mice by intraperitoneal vaccination against challenge in the foot pad with Mycobacterium marinum. Ng H; Welch TM; Baras M; Levy L Isr J Med Sci; 1980 Dec; 16(12):849-52. PubMed ID: 7451112 [TBL] [Abstract][Full Text] [Related]
5. The disease of CBA and BALB/c mice that follows inoculation of a small number of Mycobacterium lepraemurium into the hind foot pad. Silbaq F; Mor N; Levy L; Bercovier H Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):681-9. PubMed ID: 2280119 [TBL] [Abstract][Full Text] [Related]
6. Importance of the footpad lesion in the mouse response to local inoculation of Mycobacterium marinum. Mor N; Levy L Ann Inst Pasteur Microbiol (1985); 1985; 136A(2):191-201. PubMed ID: 4004150 [TBL] [Abstract][Full Text] [Related]
7. Enhanced anti-cancer efficacy on lymph node metastasis using peplomycin adsorbed on small activated carbon particles. Ito M; Hagiwara A; Iwamoto A; Shimotsuma M; Yoneyama C; Sasabe T; Takahashi T Anticancer Drug Des; 1991 Jul; 6(3):169-77. PubMed ID: 1714736 [TBL] [Abstract][Full Text] [Related]
8. Response in distant lymph nodes of mice to infection in the hind footpad with Mycobacterium marinum. Mor N; Lutsky I; Levy L Infect Immun; 1980 Apr; 28(1):225-9. PubMed ID: 7380564 [TBL] [Abstract][Full Text] [Related]
9. The migration of blood-borne lymphocytes into rat popliteal lymph nodes stimulated with xenogeneic red blood cells. Kimpton WG; Poskitt DC; Dandie GW; Muller HK Immunology; 1983 Sep; 50(1):159-63. PubMed ID: 6885109 [TBL] [Abstract][Full Text] [Related]
10. The presence of systemic and local activated macrophages in mice infected in the foot pad with Mycobacterium leprae and M. marinum. Krahenbuhl JL; Welch TM; Levy L Int J Lepr Other Mycobact Dis; 1976; 44(1-2):206-15. PubMed ID: 776858 [TBL] [Abstract][Full Text] [Related]
11. Early response of lymphatic system to experimental infection with Mycobacterium kansasii and Mycobacterium scrofulaceum. Kubícková M; Svandová E; Kubín M J Hyg Epidemiol Microbiol Immunol; 1982; 26(3):259-64. PubMed ID: 7142687 [TBL] [Abstract][Full Text] [Related]
12. Draining lymph node enlargement produced by immunogenic strains of cultivable mycobacteria. Singh NB; Srivastava K; Gupta HP; Srivastava A; Mathur IS Indian J Lepr; 1986; 58(1):38-42. PubMed ID: 3528336 [TBL] [Abstract][Full Text] [Related]
13. Immunity to D-penicillamine: genetic, cellular, and chemical requirements for induction of popliteal lymph node enlargement in the mouse. Hurtenbach U; Gleichmann H; Nagata N; Gleichmann E J Immunol; 1987 Jul; 139(2):411-6. PubMed ID: 3110270 [TBL] [Abstract][Full Text] [Related]
14. The immunological consequences of antigen overload in experimental mycobacterial infections of mice. Rook GA Clin Exp Immunol; 1975 Jan; 19(1):167-77. PubMed ID: 1106912 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the immune response in mice infected with Mycobacterium marinum. Navalkar RG; Patel PJ Int J Lepr Other Mycobact Dis; 1977; 45(3):228-34. PubMed ID: 336554 [TBL] [Abstract][Full Text] [Related]
16. Methotrexate bound to carbon particles used for treating cancers with lymph node metastases in animal experiments and a clinical pilot study. Hagiwara A; Takahashi T; Sawai K; Sakakura C; Hoshima M; Ohyama T; Ohgaki M; Imanishi T; Yamamoto A; Muranishi S Cancer; 1996 Nov; 78(10):2199-209. PubMed ID: 8918415 [TBL] [Abstract][Full Text] [Related]
17. Lack of a sustained protection against murine leprosy in C3H mice vaccinated with extracts of Mycobacterium lepraemurium in admixture with Mycobacterium bovis (BCG). Turcotte R; Lemieux S Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):494-500. PubMed ID: 6763006 [TBL] [Abstract][Full Text] [Related]
18. Enhanced therapeutic efficacy on lymph node metastasis by the use of peplomycin adsorbed on small activated carbon particles. Hagiwara A; Takahashi T; Ueda T; Iwamoto A; Yamashita H; Maeda T Anticancer Res; 1988; 8(2):287-9. PubMed ID: 2452601 [TBL] [Abstract][Full Text] [Related]
19. Enhanced therapeutic efficacy of intralymph-nodal etoposide on distal lymph node metastases using a new dosage format--activated carbon particles adsorbing etoposide. Hagiwara A; Takahashi T; Sawai K; Seiki K; Ito M; Okano S; Sakakura C; Shobayashi S; Muranishi S; Tomoda H Anticancer Drug Des; 1992 Apr; 7(2):163-8. PubMed ID: 1575889 [TBL] [Abstract][Full Text] [Related]
20. [Intra-lymph nodal injection of OK-432 for treatment of lymph node metastasis]. Okano S; Sawai K; Fujioka T; Yamaguchi M; Sakakura C; Kanemitsu K; Seiki K; Hagiwara A; Takahashi T Gan To Kagaku Ryoho; 1992 Aug; 19(10 Suppl):1598-600. PubMed ID: 1530315 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]